Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1956421000168110 | Duavive 0.45/20 (bazedoxifene 20 mg + conjugated estrogens 450 microgram) modified release tablet, 7 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1956431000168113 | Duavive 0.45/20 modified release tablet, 7, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2667981000168114 | Duavive 0.45/20 (bazedoxifene 20 mg + conjugated oestrogens 450 microgram) modified release tablet, 7 tablets, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Duavive 0.45/20 modified release tablet, 7, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Duavive 0.45/20 modified release tablet, 7, blister pack | Is a | Duavive 0.45/20 (bazedoxifene 20 mg + conjugated estrogens 450 microgram) modified release tablet, 7 tablets (trade product pack) | true | Inferred relationship | Some | ||
| Duavive 0.45/20 modified release tablet, 7, blister pack | has TPUU | Duavive 0.45/20 modified release tablet | true | Inferred relationship | Some | 1 | |
| Duavive 0.45/20 modified release tablet, 7, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Duavive 0.45/20 modified release tablet, 7, blister pack | has TP | Duavive 0.45/20 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR